Autoblog aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Sep 6, 2025 5:00 AM EDT All DIYers, mechanics, and repairmen know ...

The universe's first magnetic fields may have been much weaker than we first imagined — and were roughly equivalent to the strength of the magnetic activity within the human brain, according to a new ...

Drew Swanson is a Features Article Editor from the Pacific Northwest of the United States. He is a lifelong gamer with a passion for a variety of genres. A connoisseur of everything from JRPGs and ...

Stuffcool is my favorite Indian charging brand, and the accessory maker consistently rolls out interesting products. I've used most of its power banks over the years, and they've held up really well.

There must be something about the human brain that’s different from the brains of other animals — something that enables humans to plan, imagine the future, solve crossword puzzles, tell sarcastic ...

Kōnane was once a national pastime, played by peasants and rulers alike. Now John Kaʻohelauliʻi has made it his mission to bring it back.

The surgeon of 12-year-old Sophia Forchas, one of the 18 children injured in the shooting at Annunciation Catholic Church in Minneapolis, says she is still in critical condition 10 days after the ...

Three former Google X scientists aim to give you a second brain virtually — not in the sci-fi or chip-in-your-head sense, but through an AI-powered app that gains context by listening to everything ...

South Korean magnet manufacturer JS Link America has announced plans to invest $233 million in a new rare earth magnet production facility in Columbia, Georgia. According to a September 3 release from ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...

CALABASAS, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering ...